MedTrace Logo

Juice Plus Inflammaging and Cardiovascular Disease Prevention Study

NCT04003935 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2020-05-29

No results posted yet for this study

Summary

Low- grade inflammation is a pathological feature of a wide range of chronic conditions, including the metabolic syndrome, cardiovascular diseases (CVD) and the accelerated reduction in bone density. Previous research shows that diets rich in fruits and vegetables can reduce chronic inflammation. To date there is no data on multiyear clinical interventions assessing the effect of plant-based dietary supplements on low-grade inflammation, cardiovascular disease prevention and indicators of biological aging, including individuals' cognitive function. In this study, the investigators are thus exploring whether separate ingestions of two plant-based nutritional products over 2 years, are able to modulate low-grade inflammation, parameters of CVD prevention, circulating micronutrients, upper respiratory tract- and gastro-intestinal symptoms, quality of life, indicators of biological aging, and cognitive function in overweight seniors.

Conditions

  • Overweight or Obesity

Interventions

OTHER

Juice Plus+ Complete

Plant-based smoothie; maintaining habitual diet.

DIETARY_SUPPLEMENT

Juice Plus+ Premium

Fruit and vegetable juice concentrate; maintaining habitual diet.

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • Green Beat

    lead OTHER

Principal Investigators

  • Manfred Lamprecht, PhD · Medical University of Graz

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-05-27
Completion
2020-05-27

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04003935 on ClinicalTrials.gov